Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.

被引：0
|
作者：
Goel, Vivek [1 ]
Malik, Manish [2 ]
Bhalla, A. K. [3 ]
机构：
[1] Apollo Multispecialty Hosp, Nephrol, Kolkata, India
[2] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
[3] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 9S期
关键词：
D O I：
10.1097/01.tp.0001065280.60236.aa
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
305.7
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population
    Lalan, Shwetal
    Abdel-Rahman, Susan
    Gaedigk, Andrea
    Leeder, J. Steven
    Warady, Bradley A.
    Dai, Hongying
    Blowey, Douglas
    PEDIATRIC NEPHROLOGY, 2014, 29 (10) : 2039 - 2049
  • [32] CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children
    Alvarez-Eliasa, A. C.
    Garcia-Rocaa, P.
    Velasquez-Jones, L.
    Valverde, S.
    Varela-Fascinetto, G.
    Medeiros, M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (02) : 631 - 634
  • [33] Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population
    Shwetal Lalan
    Susan Abdel-Rahman
    Andrea Gaedigk
    J. Steven Leeder
    Bradley A. Warady
    Hongying Dai
    Douglas Blowey
    Pediatric Nephrology, 2014, 29 : 2039 - 2049
  • [34] Dosing Tacrolimus Based on CYP3A5 Genotype: Will It Improve Clinical Outcome?
    van Gelder, T.
    Hesselink, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (06) : 640 - 641
  • [35] CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients
    Yanik, Megan V.
    Seifert, Michael E.
    Locke, Jayme E.
    Hauptfeld-Dolejsek, Vera
    Crowley, Michael R.
    Cutter, Gary R.
    Mannon, Roslyn B.
    Feig, Daniel I.
    Limdi, Nita A.
    PEDIATRIC TRANSPLANTATION, 2019, 23 (05)
  • [36] Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients
    Largeau, Berenger
    Barin-Le Guellec, Chantal
    Longuet, Helene
    Lesne, Philippe
    Bouvarel, Antoine
    Preteseille, Laura
    Marquet, Pierre
    Halimi, Jean-Michel
    Buchler, Matthias
    Gatault, Philippe
    Noble, Johan
    PROGRESS IN TRANSPLANTATION, 2019, 29 (04) : 300 - 308
  • [37] Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
    Kagaya, Hideaki
    Niioka, Takenori
    Saito, Mitsuru
    Inoue, Takamitsu
    Numakura, Kazuyuki
    Yamamoto, Ryohei
    Akamine, Yumiko
    Habuchi, Tomonori
    Satoh, Shigeru
    Miura, Masatomo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (03)
  • [38] Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
    Lenain, Remi
    Maanaoui, Mehdi
    Hamroun, Aghiles
    Larrue, Romain
    Van Der Hauwaert, Cynthia
    Gibier, Jean-Baptiste
    Gnemmi, Viviane
    Gomis, Sebastien
    Labalette, Myriam
    Broly, Franck
    Hennart, Benjamin
    Pottier, Nicolas
    Hazzan, Marc
    Cauffiez, Christelle
    Glowacki, Francois
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (10):
  • [39] Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
    Xi Luo
    Li-jun Zhu
    Ning-fang Cai
    Li-yun Zheng
    Ze-neng Cheng
    Acta Pharmacologica Sinica, 2016, 37 : 555 - 560
  • [40] Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
    Luo, Xi
    Zhu, Li-jun
    Cai, Ning-fang
    Zheng, Li-yun
    Cheng, Ze-neng
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (04) : 555 - 560
12345